Risk Factors Update Summary
- Risks and uncertainties arising from bankruptcy, if pursued, were added to the risk factors.
- Added risks related to realizing benefits from license and collaboration agreements with Zylox - Tonbridge.
- Mentioned the need to raise additional funds through equity offerings to regain Nasdaq compliance.
- Added details about a financing agreement with Zylox - Tonbridge for $7.5 million.
- Disclosed the outstanding debt amount of $14.3 million as of December 31, 2023.
- Added information about the potential delisting from Nasdaq due to non-compliance with listing requirements.
- Discussed the impact of Zylox - Tonbridge's significant control over certain matters in the business.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1506928&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.